MDXG Q4 2018 Earnings — MiMedx Group, Inc. Revenue & Financial Results | Market Cap Arena

MDXGMiMedx Group, Inc.

$666M

Q4 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$93M+5.8% YoY

Gross Profit

$82M88.8% margin

Operating Income

-$9M-9.7% margin

Net Income

-$36M-39.1% margin

EPS (Diluted)

$-0.34

QoQ Revenue Growth

+6.5%

Cash Flow

Operating Cash Flow

$2M

Free Cash Flow

-$430,000

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$123M

Total Liabilities

$73M

Stockholders' Equity

$50M

Cash & Equivalents

$45M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$93M	$88M	+5.8%
Gross Profit	$82M	$79M	+3.6%
Operating Income	-$9M	$24M	-137.3%
Net Income	-$36M	$35M	-203.9%